Investor Center
Investor Center

CORPORATE OVERVIEW

Jazz Pharmaceuticals plc is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. Our strategy is to create shareholder value by:

  • Growing sales of the existing products in our portfolio, including by identifying new growth opportunities;
  • Acquiring additional differentiated products that are on the market or product candidates that are in late-stage development; and
  • Pursuing focused development of a pipeline of post-discovery differentiated product candidates.

We have made substantial progress in the execution of our strategy. We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology.

EVENTS

  • Aug 09, 2016Download Event Supporting Material Q2 2016 Jazz Pharmaceuticals Earnings Conference Call
  • Jun 20, 2016Jazz Pharmaceuticals JZP-110 Investor Update
  • Jun 08, 2016Jazz Pharmaceuticals at Goldman Sachs 37th Annual Global Healthcare Conference
  • May 31, 2016Jazz Pharmaceuticals Acquisition of Celator Pharmaceuticals
  • View all events

    Data provided by Nasdaq. Minimum 15 minutes delayed.